Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
IBM ( IBM - Analyst Report ) finally broke a multi-quarter slump in the top line with fourth-quarter revenue of $29.3 billion, which surpassed the Zacks Consensus Estimate of $29.18 billion. Non-GAAP earnings per share of $5.39 improved 14% from last year and beat the Zacks Consensus Estimate by about 2.7%.
For a while now, IBM's revenue and EPS have been going in different directions, with the former slumping slightly while the latter was able to eke out gains. The top line weakness was attributed to slowing IT spending, which had a big impact on the entire tech sector given IBM's status as a bellwether.
Today's quarterly performance by no means signals a rollicking industry for the fourth quarter, but it does suggest some improvement. It could also be a big benefit to earnings season in general, which didn't inspire much confidence to begin with and hasn't been that encouraging so far.
Revenue was still down 1% year over year, though was flat when adjusting for currency. It was up 1% excluding divested RSS business adjusting for currency. Meanwhile, IBM's earnings surprise may be small, but it gets the company back into the green after only matching in the third quarter. Before then, the company had a very impressive record of consecutive EPS surprises.
For the full year, non-GAAP earnings per share of $15.25 was up 13% and ahead of the Zacks Consensus Estimate at $15.09. Revenue was down 2% at $104.5 billion.
For 2013, IBM expects non-GAAP earnings per share of at least $16.70, compared to our estimate of $16.58.
At the moment, IBM is stuck at a Zacks Rank #4 (Sell). Out of 22 total estimates, there have been no upward revisions in the past 60 days, but there have been 5 to the downside. We'll have to wait and see if today's quarterly report will be enough to lift the Zacks Rank.
We have always believed that IBM had a good long-term picture, due to its key growth initiatives, strong product pipeline, expansion in emerging markets and continuous acquisitions. The short-term, though, was a question mark. Perhaps this quarter will get it moving in the right direction again.
IBM is certainly moving in the right direction after hours, with shares up approximately 3% at this writing.
Stay tuned for a much more in-depth report on IBM's fourth quarter...
Read the full Analyst Report on IBM